← Leaderboards
William Barrow
Oklahoma State University Stillwater
$5,160,219
Attributed
$5,160,219
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $915.9K · FY2010–13$1M$750K$500K$250K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$5,160,219 · 3
By mechanism
R01$4,666,869 · 2
R21$493,350 · 1
Top collaborators
No co-investigators on record.
Most similar at Oklahoma State University Stillwater
Same institution · by research overlap
- Jeffrey A Hadwiger$1,434,147
- Junpeng Deng$4,147,664
- Carey N Pope$4,438,594
- Nicholas E Dickenson$1,192,735
- Richard A Bunce$491,851
Others in their field
Top investigators on “Dihydrofolate Reductase”
- Hua Linda Cai · University Of California Los Angeles$9,038,147
- Dennis L Wright · University Of Connecticut Sch Of Med/Dnt$7,806,748
- Eugene I Shakhnovich · Harvard University$7,483,253
- Lizbeth K. Hedstrom · Brandeis University$6,204,611
- Robert Callender · Yeshiva University$5,769,025
- Pradipsinh K. Rathod · Catholic University Of America$5,682,180
Research focus
Dihydrofolate ReductaseBacillus AnthracisMolecular CloningDrug Screening /EvaluationRecombinant ProteinsAnimal ModelAnti-Bacterial AgentsActinomycetales InfectionArtsAnthrax DiseaseCarbonBacillus Anthracis SporeBacterial ProteinsBactericideAidsBinding (Molecular Function)BerlinAntimicrobialBiochemistryAntitubercular AgentsBreathingCaliforniaBehaviorBase
Grant awards (9)
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis$732,571
R01 · FY2013 · AI · contact PI
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis$842,854
R01 · FY2012 · AI · contact PI
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis$915,887
R01 · FY2011 · AI · contact PI
Broad-spectrum Antifolates for Treatment of Drug Resistant Bacillus anthracis$875,000
R01 · FY2010 · AI · contact PI
Narrow-Spectrum Drug Targets for Bacillus anthracis$265,650
R21 · FY2004 · AI
Antifolates Against Mycobacterial Infections in AIDS$425,369
R01 · FY2003 · AI
Narrow-Spectrum Drug Targets for Bacillus anthracis$227,700
R21 · FY2003 · AI
Antifolates Against Mycobacterial Infections in AIDS$425,369
R01 · FY2002 · AI
Antifolates Against Mycobacterial Infections in AIDS$449,819
R01 · FY2001 · AI